New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Welcome to the HDL

Huntington's Harbor Lighthouse.
This is the Huntington Harbor Lighthouse which is located north of Long Island where Dr. George Huntington observed and wrote about Huntington's Disease patients. It was chosen as a symbol of this Web site which will continue to offer a beacon of hope to families coping with Huntington's Disease until all of our ships are home safe in harbor.
© Kraig Anderson. Used by permission.

Welcome
The HDLighthouse mission is to present and explain the latest research findings so that HD families can become proactive in their care, have hope for the future, and make good decisions in the present.

Welcome to the new Huntington's Disease Lighthouse site
Beginners Start Here
Disclaimer & Privacy Policy
Meet the Huntington's disease web team
Navigation Explained
All Files On This Site.
Huntington's Disease Updates
25 Jul 2010
Reduced Creatine Kinase
Reduced creatine kinase is a promising biomarker.
 
25 Jul 2010
Sirtuin Inhibition Achieves Neuroprotection by Decreasing Sterol Biosynthesis
SIRT2 inhibition emerges as a promising therapeutic strategy.
 
24 May 2010
Neurosearch Amends the ACR-16 Results
Statistical significance not achieved on primary endpoint.
 
24 May 2010
Cargo Recognition is Impaired in HD
Autophagy increases but is impaired, leading to an increase of the HD protein in the cytosol.
 
14 Apr 2010
CoQ10 and Minocycline not helpful in Mouse Model
Neither CoQ10 nor minocycline were helpful in the R6/2 mouse and high doses of minocycline resulted in decreased survival time.
 
3 Feb 2010
The European trial of ACR16 yields good results
ACR16 improves voluntary and involuntary movement. This is wonderful news!
 
31 Jan 2010
A Sirtuin Inhibitor Enters Phase1a Clinical Trials in Europe
Siena Biotech announces a safety and tolerability study with healthy volunteers, preparatory to trials in HD patients.
 
22 Dec 2009
Synaptic activity, aggregation, and memantine
Normal synaptic activity is neuroprotective, that extrasynaptic activity is toxic, and that memantine will suppress the later while leaving the former unaffected.
 
22 Dec 2009
Invitation to participate in a quality of life survey
Here is an opportunity to tell the medical professionals about quality of life issues.
 
6 Dec 2009
An interview with Dr. Jan Nolta
A trial of mesenchymal stem cell is planned for the end of 2010.
 
All Updates for Home
Your Proactive Battle With HDbluedown.gif
HDL Triad HDL Triad
You can fight back.
Your triad is exercise, diet and spirit
2blue.gif
HD Drug Pipeline HD Drug Pipeline
See the progress that HD treatments are making as they move from the lab to you.
2blue.gif
Image of pills Potential Agents
Treatment Now! Agents with potential benefits
2blue.gif
Huntington Project Logo Huntington Project
Find out what is happing in HD trials and treatments at the Huntington Project.
Creatine Now in Clinical Trials
Latest news on Creatine...
2blue.gif
Yum! Blueberries Blueberries Help Brain
Anthocyanin Promotes Neurogenesis
HD Drug Works
HD Drug Works logo Connecting HD people to HD research.
Huntington's Disease Drug Works
Community
Forum Launch HDAC Message Board & Chat
Calandar JPG Huntington's Disease Event Calendar
Coming Events, Notices
Phil Hart Photo

Managing Huntington's Disease: Visit the Navigating Life section where Contributing Author Phil Hardt's provides several tips on handling problems caused by HD.
Make better decisions now!
14 changes that could signal concern.
Eliminating suicide
HD Care Standards - The problem and the challenges.
Step by Step Social Security

Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org